H1 2013 revenue: the Group maintains positive momentum

07/17/2014

H1 2013 revenue (1 January to 30 June 2013) 

 

The Group maintains positive momentum 

 

Press release 

 

Avignon, 25 July 2013 - Naturex, the global leader in specialty plant-based natural ingredients, announces its 2013 first-half consolidated revenue:

€000s

IFRS
 Unaudited data

FY 2013  FY 2012  Change (%)  Change (%)
 at constant exchange rates  
1st quarter 83,196 73,473 +13.2% +14.4%
2nd quarter 82,558 73,684 +12.0% +12.5%
H1 revenue  165,754  147,157  +12.6%  +13.4% 

 

Consolidated revenue for the 2013 first half amounted to €165.8 million, up 12.6% from last year's same period.

At constant exchange rates, first-half sales rose 13.4% with 11% from organic growth and 2.4% from changes in Group structure (mainly Decas Botanical Synergies). The net currency effect for the period was -0.8%.

This good performance, with steady growth momentum the last two quarters, reflects both Naturex's strategy to build an increasingly differentiated product offering and extended geographical coverage.

 

Positive sales trends by business 

€000s

IFRS
 Unaudited data

H1 FY 2013  H1 FY 2012 

Change 

(%) 

Revenue mix 

(%) 

Change (%)
 at constant exchange rates 
Food & Beverage 94,149 94,309 -0.2% 56.8% +0.9%
Nutrition & Health 59,064 44,322 +33.3% 35.6% +33.6%
Personal Care 3,025 2,587 +16.9% 1.8% +17.2%
Toll-Manufacturing and misc. 9,516 5,939 +60.2% 5.7% +60.2%

  

 

 

Solid geographic positions 

€000s

IFRS
 Unaudited data

H1 FY 2013  H1* FY 2012 

Change 

(%) 

Revenue mix 

(%) 

Change (%)
 at constant exchange rates 
 
Europe/Africa 78,348 71,370 +9.8% 47.3% +10.1%
Americas 68,504 57,896 +18.3% 41.3% +19.6%
Asia/Pacific 18,902 17,891 +5.6% 11.4% +6.6%
               

* To take into account the geographic breakdown of our Sales Divisions, countries of the Middle East region previously included in Europe/Africa are henceforth presented within the Asia/Pacific region. The revenue breakdown by region for the 2012 first half in consequence takes into account this new presentation. 

 

All regions registered good gains, reflecting proactive performances by the sales network both in developed and emerging countries accounting for 16.4% of Group sales:

 

"We are very satisfied with the level of organic growth in the 2013 first half in an economic environment that remains difficult. This positive trend should continue in the second half though with a marginal slowdown expected from the less favourable comparison base with the same period in 2012", commented Naturex's Chairman-CEO, Thierry Lambert. "Our teams throughout the world will pursue their efforts to multiply initiatives to increase the differentiation of our offering, strengthen our positioning and accelerate our development in regions and markets with strong growth potential." 

 

 

You can receive all financial information of Naturex free of charge by signing up at: www.naturex.fr  

Financial schedule 

-          2013 first-half results 30 August 2013

Upcoming events 

-          Analysts meeting (SFAF - French Society of Financial Analysts), Paris 4 September 2013

 

 

Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B

 

Total number of shares comprising the share capital: 7,826,565

ISIN FR0000054694

 

Naturex is a component of the CAC Small and Gaïa indexes.

Naturex is eligible for the "long only" Deferred Settlement Service (SRD).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex’s ADRs are traded over-the-counter in the United States under the symbol NTUXY.

 

SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

 

About Naturex  

Naturex is a global leader in speciality plant-based natural ingredients.

The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex’s head office is based in Avignon. The company employs more than 1,300 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland) as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 20 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, UAE, Thailand, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).

Naturex's development is supported by positive underlying trends linked to the fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.

 

 

 Contacts   

 

Thierry Lambert  

Chairman and Chief Executive Officer

Tel.: +33 (0)4 90 23 96 89

t.lambert@naturex.com

 

 

 

 

Thierry Bertrand Lambert  

Chief Financial Officer

Tel.: +33 (0)4 90 23 96 89

t.blambert@naturex.com

 

Carole Alexandre 

Investor Relations

Tel.: +33 (0)4 90 23 78 28

c.alexandre@naturex.com

Anne Catherine Bonjour 

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

acbonjour@actus.fr

 

 

actu_161_Fichierpdf.pdf
 
of 233
BACK